A specific additional value of the algorithm is that, as previously shown [28, 38, 43], it could not only identify MR TK proteins, representing individual, pharmacologically accessible dependencies of the tumor, but also TKs representing potential synergistic MR-pair as candidate dependencies for combination therapy. This evidence concerns the gene CDC42 and neoplasm.